Inflammatory Mediators of Acute Kidney Injury in Intensive Care

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUppsala University

About this trial

Acute kidney injury (AKI) affects more than 50% of patients admitted to the intensive care unit. The most common underlying cause is sepsis. Severe AKI in combination with sepsis is associated with high mortality. The mechanisms for sepsis-induced AKI are largely unknown. Our hypothesis is that the inflammatory response to an infection cause collateral damage to host tissue and contributes to the development of AKI. In this study we want to investigate the presence of novel inflammatory mediators in patients with sepsis, patients subjected to major surgery (sterile inflammation) and non-inflamed patients and correlate their levels with the risk for AKI.

Eligibility criteria

Qualifiers

with septic shock or

post major surgery or

after intoxication with a chemical compund

Disqualifiers

Pregnancy or

Breast feeding or

Chronic kidney disease or

intoxication with nephrotoxic compund or

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Uppsala University

Lead sponsor

Maastricht University

Collaborator